New Chief Executive Officer for Britest
Britest Limited would like to announce that, as of 1st April 2024, Dr Kirk Malone will become Chief Executive Officer (CEO) and will join the Board of Britest as Executive Director.
Kirk is currently the Commercial Director of Britest, having joined the company in May 2023. Prior to this, he held a number of positions at the University of Manchester at the interface of academia and industry, most recently as Director of Commercialisation at the Manchester Institute of Biotechnology. Kirk has a PhD in organic chemistry from the University of Edinburgh, and extensive experience in interdisciplinary science, project and R&D management, and business development across multiple sectors.
Sue Fleet, Chair of the Board of Britest, said “On behalf of all the Directors of Britest, I am very pleased to appoint Kirk to the role of CEO. The Board has been impressed with how business has progressed since he joined the company just under a year ago, a credit to his efforts as Commercial Director, but also a testament to the hard work of the whole Britest team. We look forward to seeing Britest continue to develop to best serve its Members and wider process industry organisations.”
Kirk Malone responded “I am grateful for the confidence of the Board, and for all their support since I joined Britest. It is a pleasure to work with our Member organisations and partners on a range of interesting projects and collaborations, and I am fortunate to do so with such amazing colleagues. It is an honour to become CEO and I am keen to continue to apply Britest’s innovations to develop safer, more productive and sustainable processes.”
It is an honour to become CEO and I am keen to continue to apply Britest’s innovations to develop safer, more productive and sustainable processes.
About Britest
Founded in 2001, Britest Limited supports organisations to sustainably grow through better process understanding. Our expert facilitators use proprietary methods, tools and techniques to define, structure and translate knowledge into economic & environmental value. By optimising the processes of our industrial clients, Britest has generated over £1Bn in value across multiple manufacturing sectors, including chemicals, pharmaceuticals, biotechnology, materials, food and energy.
Britest currently has the following organisations as Members: AstraZeneca, Biogen, Johnson Matthey, Pfizer, Robinson Brothers, Sterling Pharma Solutions, Quotient Sciences.
27/03/24